Ying Li

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 2

Top Topics

Transcription Factor

Combination Therapy

Emergency Department

Top Venues

Thoracic cancer

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Jiaqi Ji, Shuping Yang, Lingling Zu, Yongwen Li, Ying Li
Deubiquitinating enzyme USP41 promotes lung cancer cell proliferation and migration. Thoracic cancer 12 (7) (2021)
Yueshan Fan, Dong Wang, Chenxu Rao, Ying Li, Hongtao Rong, Zengguang Wang, Jianning Zhang
Atorvastatin Combined with Low-Dose Dexamethasone Treatment Protects Endothelial Function Impaired by Chronic Subdural Hematoma via the Transcription Factor KLF-2. Drug design, development and therapy 14 (2020)